Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “AMIDINES”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 91 records · Page 5Linked to original sources
PubMed2002

Novel coordinatively unsaturated bimetallic complexes, [(eta5-C5Me5)Ru(mu2-iPrNC(Me)=N(i)Pr)Ru(eta5-C5Me5)]+: a bridging amidinate ligand perpendicular to the metal-metal axis effectively stabilizes the highly reactive cationic diruthenium species.

Coordinatively unsaturated diruthenium complexes, [(eta5-C5Me5)Ru(mu2-iPrNC(Me)=NiPr)Ru(eta5-C5Me5)]+, of which crystallography revealed structures bearing a bridging amidinate ligand perpendicular to the Ru-Ru axis, were synthesized by anion exchange of [(eta5-C3Me5(Ru(mu2-iPrNC(Me)=NiPr)Ru(eta5-C5Me5)]+ Br- by weakly coordinating anions. Variable-temperature NMR showed rapid motion of the bridging amidinate ligand. The coordinatively unsaturated nature of the cationic complexes provides their high reactivity toward a series of two electron donor ligands. Oxidative addition of molecular hydrogen occurred to give [(eta5-C5Me5)Ru(mu2-iPrNC(Me)=NiPr)(mu-H)Ru(eta5-C5Me5)(H)]+, which was isolated and characterized.

Journal Article↗
PubMed2003

A weak, short metal-metal bond in a chromium(II) amidinate complex.

Treatment of chromium(II) chloride with 2 equiv of Li[tBuNC(CH3)NtBu], Li[iPrNC(CH3)NiPr], or Li[tBuNC(CH3)NEt] (prepared from the corresponding carbodiimides and methyllithium) afforded Cr[tBuNC(CH3)NtBu]2 (1, 50%), Cr[iPrNC(CH3)NiPr]2 (2, 54%), and [Cr(tBuNC(CH3)NEt)2]2 (3, 58%) as deep blue, purple, and amber or metallic green crystals, respectively. Cr[tBuNC(CH3)NtBu]2 and Cr[iPrNC(CH3)NiPr]2 possess monomeric structures in the solid state with tetrahedral and square planar geometries about the chromium centers, respectively. [Cr(tBuNC(CH3)NEt)2]2 exists as a dimer in the solid state, with two mu2-amidinate ligands, two eta2-amidinate ligands, and a chromium-chromium bond length of 1.9601(12) A. [Cr(tBuNC(CH3)NEt)2]2 is diamagnetic in the solid state, as determined by magnetic susceptibility measurement and CP/MAS 13C NMR spectroscopy. However, [Cr(tBuNC(CH3)NEt)2]2 dissociates into paramagnetic monomers in solution, as determined by observation of extremely broad peaks in the 1H NMR spectra in cyclohexane-d12 and benzene-d6, a solution magnetic moment measurement, and by solution molecular weight measurements in benzene. The combined results suggest that the chromium-chromium bond strength in [Cr(tBuNC(CH3)NEt)2]2 is weak and cannot exceed the difference in solvation energies between the dimer and two monomers, plus any increase in metal-nitrogen bond strengths in the monomers.

Journal Article↗
PubMed1999

Prodrugs for amidines: synthesis and anti-Pneumocystis carinii activity of carbamates of 2,5-bis(4-amidinophenyl)furan.

Syntheses of several carbamate analogues of 2, 5-bis(4-amidinophenyl)furan (1) under mild conditions and their evaluation as prodrugs against Pneumocystis carinii pneumonia (PCP) in an immunosuppressed rat model are described. Thus, nine new bis-carbamates: methoxycarbonyl (2), 2,2,2-trichloroethoxycarbonyl (3), ethylthiocarbonyl (4), benzyloxycarbonyl (5), (4-methyl-2-oxo-1, 3-dioxol-4-en-5-yl)methoxycarbonyl (6), phenoxycarbonyl (7), 4-fluorophenoxycarbonyl (8), 4-methoxyphenoxycarbonyl (9), and (1-acetoxy)ethoxycarbonyl (10) and a bis-carbonate ethoxycarbonyloxy (11) of the bis-amidine 1 have been synthesized and evaluated. The in vivo results show that the 4-fluorophenyl carbamate 8 and the 4-methoxyphenyl carbamate 9 in this series had the best anti-PCP activity by both intravenous and oral administration at a dosage level of 22 mol and 33 micromol/kg/day, respectively. Compounds 3-7 were also more active than the parent drug (1) on oral administration. The acute toxicity usually exhibited by the parent amidine 1 at a dosage level of 22 micromol/kg/day on intravenous administration has been significantly reduced by the prodrug modifications, with the exception of compound 10 which exhibited some toxicity. This report also describes the synthesis of several aryl-alkyl and aryl-aryl carbonates (12-14, 16-23) as efficient reagents for the preparation of carbamate derivatives from bis-arylamidines.

Administration, Oral↗
PubMed2000

Chemoselective reactions of amidines: selective formation of iminopyrimidine regioisomers

The dramatic effect of base on the chemoselectivity of the reaction of amidines with substituted 3-phenyl-2-propynylnitriles is demonstrated. Amidine 1 can be added to cyanoalkyne 2 to give iminopyrimidine isomer 3 with high selectivity. The addition of 2 equiv of NaHMDS completely reverses the selectivity of the reaction, yielding isomer 4 almost exclusively. This method has been used to prepare a variety of substituted 4-iminopyrimidines.

Journal Article↗
PubMed2006

Synthesis and reactivity of mono(amidinate) organoiron(II) complexes.

The mono(amidinate) iron(ii) ferrate complex [{PhC(NAr)(2)}FeCl(micro-Cl)Li(THF)(3)] (1, Ar = 2,6-iPr(2)C(6)H(3)) was prepared and was found to undergo ligand redistribution in non-coordinating solvents to give the homoleptic [{PhC(NAr)(2)}(2)Fe] (2) as the only isolable product. Reaction of with alkylating agents also induces this redistribution, but the presence of pyridine allows isolation of the four-coordinate 14 VE monoalkyl complex [{PhC(NAr)(2)}FeCH(2)SiMe(3)(py)] (4). Generation of the 12 VE alkyl via pyridine abstraction from 4 by B(C(6)F(5))(3) again induced ligand redistribution. Attempts to trap a 12 VE alkyl species with CO led to the isolation of a dimeric Fe(0)-Li-ferrate complex (3) with a carbamoyl ligand, derived from CO insertion into the iron-amidinate bond.

Journal Article↗
PubMed2000

Effect of amidine derivatives on Leishmania amazonensis axenic amastigotes. Preliminary studies of structure-activity relationships

In a previous work, searching for new drugs with high efficiency and low toxicity, the in vitro antileishmanial activity of a series of seven amidine derivatives against Leishmania amazonensis promastigotes was reported. In order to compare the potential difference in the susceptibility between the two developmental stages of the parasite to these compounds, an analysis of the effects of these amidine derivatives on promastigotes and axenically grown amastigotes of L. amazonensis was carried out. Among the N,N'-diphenyl-4-R-benzamidine (where R = H, Cl, Br, CN, NO2, CH3 and OCH3) derivatives studied, the most active compounds in both developmental stages were those with -Br, -Cl, -NO2, and -OCH3 substituents, the nonsubstituted ones being the least active. However, the susceptibility to the drugs varied in these forms, being higher in promastigotes. The electronic theoretical parameters calculated by molecular modelling using the semi-empirical AM1 method showed good correlation with substituent constant (sigma para, sigma 1 and F). The chemical structure and biological activity relationships were investigated in all compounds, although a small but significant correlation was observed. The obtained results suggest that other factors than the electronic parameters have an influence on the biological response.

Journal Article↗
PubMed1999

Amidine derivatives are highly effective against Trypanosoma evansi trypomastigotes.

The in vitro effect of N,N'-diphenyl-4-R-benzamidine (where R = H, CN, Br, Cl, CH3, OCH3 and NO2) in three isolates of Trypanosoma evansi was studied. The compounds were solubilized in dimethysulphoxide (DMSO) and tested in a concentration range of 5 to 160 micrograms/ml. The parasites were isolated from a horse, a dog and a coati. They were maintained in immunosuppressed rats, since they could not be cultured in vitro, and further purified through a diethylaminoethanol (DEAE) column. The trypomastigotes obtained were mixed with different concentrations of the drugs and after incubation at 26 degrees C for 24 h, the remaining parasites were counted in a Neubauer chamber. The percentage of inhibition was evaluated compared with the control, without the drugs. Most of the amidine derivatives showed high activity against the three T. evansi isolates, but different patterns of sensitivity to the tested compounds were observed. At least four compounds with Br, Cl, OCH3 and NO2 as substituents, were much more effective than Berenil [4,4'-(diazoamine)-dibenzamidine aceturate], the reference drug used, which is included in the same chemical class of amidines.

Animals↗
PubMed2002

Synthesis and antitumour activity of a series of cyclic amidines of 2,3-dihydro-1H-1,5-benzodiazepines.

2,3-Dihydro-1H-1,5-benzodiazepine amidines were prepared by nucleophilic substitution of 2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-2-thiones. Evaluation of the 13 synthesised amidines as antitumour agents was carried out in vitro against 60 human tumour cell lines at the National Cancer Institute, Bethesda, USA. The screening revealed a moderate cell growth inhibition of two derivatives on all cell lines at concentrations ranging from 10(-5) to 10(-4) mol/l. Log P values were theoretically calculated. The more active derivatives were found to exhibit a higher lipophilicity.

Antineoplastic Agents↗
PubMed1982

The selectivity of amino acid and peptide amidination with O-methylisourea.

Selectivity of amidination using ornithine as model amino acid was investigated in detail. The results obtained were taken advantage of for studying the reactions with other polyfunctional amino acids: beta-tyrosine, isoserine, 2,3-diaminopropionic acid, 2,6-diamino-7-hydroxyazelaic acid and with the pentapeptide amide, edeine A. It was found that, if the appropriate conditions are maintained, selective amidination of more basic amino groups of polyamino compounds is possible when these groups are bound to the primary alkyl.

Amides↗
PubMed1994

Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivo.

A novel series of 5-amino-1,4-benzodiazepin-2-one derivatives (amidines), which contain a cationic solubilizing group and which are antagonists for the cholecystokinin (CCK)-B receptor, have been identified. Optimization of this series led to the identification of an azabicyclononane amidine, L-740,093 [N-[(3R)-5-(3-azabicyclo[3.2.2]nonan-3-yl)-2,3-dihydro-1-methyl-2- oxo- 1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea], that bound with high affinity of CCK-B receptors from guinea pig cerebral cortex (IC50 of 0.1 nM) and had a CCK-B/CCK-A receptor selectivity of 16,000. In comparison, L-365,260 had 85-fold lower affinity (8.5 nM) and was only 87-fold selective for CCK-B over CCK-A receptors. L-740,093 bound with high affinity to guinea pig gastrin receptors in vitro (IC50 of 0.04 nM). Electrophysiological studies on slices of rat ventromedial hypothalamic nucleus showed that L-740,093 produced rightward shifts of the concentration-response curve for the CCK-B receptor agonist pentagastrin (Kb of 0.06 nM). L-740,093 blocked pentagastrin-induced gastric acid secretion in anesthetized rats with a 50% inhibitory dose of 0.01 mg/kg, intraperitoneally, showing 100-fold greater activity, compared with L-365,260 (50% inhibitory dose of 1 mg/kg, intraperitoneally). An ex vivo binding assay in mice was used to investigate the interaction of L-740,093 with central CCK binding sites. After intravenous administration, L-740,093 inhibited ex vivo binding dose dependently, with a 50% effective dose of 0.2 mg/kg. These studies demonstrate that L-740,093 is the most potent and selective CCK-B antagonist yet described and that it has excellent central nervous system penetration.

Animals↗
PubMed2003

Structure-activity studies of novel amidine analogues of chlorambucil: correlation of cytotoxic activity with DNA-binding affinity and topoisomerase II inhibition.

A series of amidine analogues of chlorambucil (9-12), where 5-[4-(N-alkylamidino)phenyl]-2-furancarboxamide and the chlorambucil moiety are linked by a NH(CH(2))(2)NH chain, was synthesized and their cytotoxicity has been tested against the growth of human breast cancer MCF-7 cells. Evaluation of the cytotoxicity of compounds 9-12 employing a MTT assay and inhibition of [(3)H]thymidine incorporation into DNA demonstrated that these conjugates were more active than chlorambucil. Data from the ethidium displacement assay indicated that these compounds bind in the minor groove of DNA and show moderate specificity for AT base pairs. Compounds 9-12 were potent topoisomerase II inhibitors, with 50% inhibitory concentrations (IC(50))ranging from 10 to 40 microM. The cytotoxicity of the compounds 9-12 correlates with their DNA-binding affinities and their relative potency as topoisomerase II inhibitors. Altogether, these data suggest (i) that the cytotoxic activity of compounds 9-12 may be due to the combined effects of alkylation, DNA-minor groove binding, and (ii) that N-(2-aminoethyl)-5-(4-N-alkylamidinophenyl)-2-furancarboxamides (5-8) ligands are suitable linkers that favors DNA targeting by chlorambucil derivatives.

Amidines↗
PubMed2000

A potent inhibitor of inducible nitric oxide synthase, ONO-1714, a cyclic amidine derivative.

(1S,5S,6R,7R)-7-Chloro-3-imino-5-methyl-2-azabicyclo[4.1.0]heptane hydrochloride (ONO-1714), a novel cyclic amidine analogue, inhibits human inducible nitric oxide (iNOS) with a K(i) of 1.88 nM and rodent iNOS with similar potency in vitro. ONO-1714 was found to be 10-fold selective for human iNOS over human endothelial NOS (ecNOS). When the inhibitory activity of ONO-1714 was compared for iNOS, it was found to be 451-fold and >20,000-fold more potent than L-NMMA and aminoguanidine (AG), respectively. In terms of human iNOS selectivity, ONO-1714 was approximately 34- and 2-fold more selective for iNOS than L-NMMA and AG, respectively. ONO-1714 inhibited the LPS-induced elevation of plasma nitrate/nitrite in mice with an ID(50) value of 0.010 mg/kg, s.c. The maximum tolerated dose of ONO-1714 was 30 mg/kg, i.v. Thus, ONO-1714 represents one of the most potent iNOS inhibitors in vitro and in vivo to date and has great potentials for use as an inhibitor for clarifying the pathophysiological roles of iNOS and for use as a therapeutic agent.

Amidines↗
PubMed1992

Condensation of vaporous amino acids in the presence of silica. Formation of bi- and tricyclic amidines.

Amino acids (alanine, valine, norvaline, leucine, and 2-aminoisobutyric acid) were subjected to repeated (5-9 times) sublimation in the presence of silica at temperature of 220-240 degrees C. The major amino acid condensation products were diketopiperazines (DKPs) in yields of 27-89%. Mixtures of by-products have been isolated from the DKPs by means of chloroform extraction. On the basis of fast atom bombardment mass spectrometric studies of the mixtures it is proposed that under these conditions further dehydration proceeds resulting in bicyclic (BCA) and tricyclic (TCA) amidine derivatives of DKPs; the BCA formation has been confirmed by means of IR and 1H NMR spectroscopy in the case of 2-aminoisobutyric acid. During the sublimation, thermal destruction of the cyclic products was also observed accompanied by the cycle degradation and cleavage of alkyl substituents. The BCAs and TCAs are considered as possible sources of linear di- and tripeptides.

Amidines↗
PubMed1976

Aromatic Tris-amidines. A new class of highly active inhibitors of trypsin-like proteases.

A number of novel aromatic Tris-amidines have been synthesized and investigated for their antiproteolytic property. The basic structure of the compounds is that of mesitylene where each of the methyl groups has been substituted with a 3- or 4-amidinophenoxy moiety. The compounds displayed considerable activity against trypsin (EC 3.4.21.4) and thrombin (EC 3.4.21.5), but proved most effective against porcine pancreatic kallikrein (EC 3.4.21.8). With this enzyme a Ki value of 2.43-10(-8) M was recorded for alpha,alpha',alpha''-tris(4-amidino-2-bromophenoxy)mesitylene at pH 8.1 and 37 degrees C. The most potent thrombin inhibitor, alpha,alpha',alpha''-tris(3-amidinophenoxy)mesitylene, had a Ki value of 6.51-10(-7) M and was also a strong overall anticoagulant. The inhibitors were able to interfere with the kinin release by human plasma kallikrein at concentrations as low as 1-10(-10) M. However, despite this remarkable antikallikrein effect and the known importance of plasma kallikrein in the activation of Hageman factor (factor XII), the compounds had only little influence on the early stages of blood coagulation.

Amidines↗
PubMed1990

Tetra-amidines exhibiting anti-proteinase activity: effects on oriented migration and in vitro invasiveness of a Chinese hamster cell line transfected with the activated human T24-Ha-ras-1 oncogene.

In the present paper we have investigated the effects of aromatic tetra-amidines on attachment, oriented migration and in vitro invasiveness of the Chinese Hamster FH06T1-1 fibroblast lung cell line, transformed with the activated human T24-Ha-ras-1 oncogene. The FH06T1-1 cell line is tumorigenic in nude mice and displays growth properties and biological features clearly distinct from those of the FH06N1-1 cell line, obtained after transfection of the same fibroblast cells with the normal Ha-ras-1 proto-oncogene. Attachment, oriented migration and invasiveness were analysed by culturing the cells on a reconstituted extracellular matrix, composed of collagen IV, laminin, entactin and heparan sulphate proteoglycans. The results obtained demonstrate that oriented migration is performed only by FH06T1-1 cells and that tetra-benzamidines are effective inhibitors of oriented migration and "in vitro" invasiveness of these tumorigenic cells. These findings should encourage further studies on the possible antimetastatic effects of these antiproteinase tetra-benzamidines on experimental animals.

Amidines↗
PubMed1989

Induction of murine erythroleukemia cell differentiation by proteinases is inhibited by aromatic poly-amidines.

The effects of the tetra benzamidine serine-proteinase inhibitor 1,3-di-(p-amidinophenoxy) -2,2- bis- (p-amidinophenoxymethyl)propane (TAPP-H) and related compounds, including halo-derivatives, were determined on the erythroid differentiation of murine erythroleukemic cells induced by trypsin and kallikrein. These aromatic poly-amidines and their halo derivatives were found to be strong inhibitors of both trypsin and kallikrein mediated induction of commitment of MEL cells to erythroid differentiation, hemoglobin synthesis and accumulation, globin mRNA production. No inhibitory effects were detected by treating proteinase-induced MEL cells with benzamidine. Only slight inhibitory activity was found after treatment of trypsin-induced MEL cells with other antiproteinase compounds widely used in the control of proteinase-dependent functions, including leupeptin, antipain and Bowman-Birk proteinase inhibitor. MEL cells induced to erythroid differentiation by proteinases could be proposed as an experimental system to test the biological activity of proteinase inhibitors.

Amidines↗
PubMed1985

Biogenic amine uptake by nerve cords from the American cockroach and the influence of amidines on amine uptake and release.

Uptake of 5-hydroxytryptamine (5-HT) by isolated whole nerve cords of the American cockroach, Periplaneta americana (L.), involved a dual component system, with one component consisting of rapid active uptake and the other of passive diffusion. Using high performance liquid chromatography with electrochemical detection, it was shown that nerve cords contained 5-HT levels of about 350 ng/g and an equivalent amount of 5-hydroxyindoleacetic acid (5-HIAA), a 5-HT metabolite not previously reported in cockroach nerve cords. Amidines had no discernable effect on uptake of 5-HT or octopamine by nerve cords or on endogenous levels of 5-HT and 5-HIAA in cords.

Amidines↗